List of Excipients in API sitagliptin and metformin hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing sitagliptin and metformin hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | JANUMET | sitagliptin and metformin hydrochloride | 0006-0078 | ALUMINUM OXIDE | |
| Merck Sharp & Dohme LLC | JANUMET | sitagliptin and metformin hydrochloride | 0006-0078 | CARNAUBA WAX | |
| Merck Sharp & Dohme LLC | JANUMET | sitagliptin and metformin hydrochloride | 0006-0078 | CELLULOSE, MICROCRYSTALLINE | |
| Merck Sharp & Dohme LLC | JANUMET | sitagliptin and metformin hydrochloride | 0006-0078 | FD&C BLUE NO. 2 | |
| Merck Sharp & Dohme LLC | JANUMET | sitagliptin and metformin hydrochloride | 0006-0078 | HYDROXYPROPYL CELLULOSE | |
| Merck Sharp & Dohme LLC | JANUMET | sitagliptin and metformin hydrochloride | 0006-0078 | HYPROMELLOSE 2208 | |
| Merck Sharp & Dohme LLC | JANUMET | sitagliptin and metformin hydrochloride | 0006-0078 | HYPROMELLOSE 2910 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing sitagliptin and metformin hydrochloride
Detailed excipient profiles for sitagliptin and metformin hydrochloride
Excipient focus: ALUMINUM OXIDE
sitagliptin and metformin hydrochloride drug variants containing ALUMINUM OXIDE
sitagliptin and metformin hydrochloride drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
sitagliptin and metformin hydrochloride drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
sitagliptin and metformin hydrochloride drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: CARNAUBA WAX
sitagliptin and metformin hydrochloride drug variants containing CARNAUBA WAX
sitagliptin and metformin hydrochloride drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
sitagliptin and metformin hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
sitagliptin and metformin hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
sitagliptin and metformin hydrochloride drug variants containing CROSCARMELLOSE SODIUM
sitagliptin and metformin hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: FD&C BLUE NO. 2
sitagliptin and metformin hydrochloride drug variants containing FD&C BLUE NO. 2
sitagliptin and metformin hydrochloride drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C YELLOW NO. 6
sitagliptin and metformin hydrochloride drug variants containing FD&C YELLOW NO. 6
sitagliptin and metformin hydrochloride drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
sitagliptin and metformin hydrochloride drug variants containing FERRIC OXIDE RED
sitagliptin and metformin hydrochloride drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
sitagliptin and metformin hydrochloride drug variants containing FERRIC OXIDE YELLOW
sitagliptin and metformin hydrochloride drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
sitagliptin and metformin hydrochloride drug variants containing FERROSOFERRIC OXIDE
sitagliptin and metformin hydrochloride drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROXYPROPYL CELLULOSE
sitagliptin and metformin hydrochloride drug variants containing HYDROXYPROPYL CELLULOSE
sitagliptin and metformin hydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE 2208
sitagliptin and metformin hydrochloride drug variants containing HYPROMELLOSE 2208
sitagliptin and metformin hydrochloride drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
sitagliptin and metformin hydrochloride drug variants containing HYPROMELLOSE 2910
sitagliptin and metformin hydrochloride drug variants not containing HYPROMELLOSE 2910
Excipient focus: INDIGOTINDISULFONATE SODIUM
sitagliptin and metformin hydrochloride drug variants containing INDIGOTINDISULFONATE SODIUM
sitagliptin and metformin hydrochloride drug variants not containing INDIGOTINDISULFONATE SODIUM
Excipient focus: KAOLIN
sitagliptin and metformin hydrochloride drug variants containing KAOLIN
sitagliptin and metformin hydrochloride drug variants not containing KAOLIN
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
sitagliptin and metformin hydrochloride drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
sitagliptin and metformin hydrochloride drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Excipient focus: MAGNESIUM STEARATE
sitagliptin and metformin hydrochloride drug variants containing MAGNESIUM STEARATE
sitagliptin and metformin hydrochloride drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALIC ACID
sitagliptin and metformin hydrochloride drug variants containing MALIC ACID
sitagliptin and metformin hydrochloride drug variants not containing MALIC ACID
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
sitagliptin and metformin hydrochloride drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | sitagliptin and metformin hydrochloride | 60505-3658 |
| >Company | >Ingredient | >NDC |
sitagliptin and metformin hydrochloride drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: POLYETHYLENE GLYCOL
sitagliptin and metformin hydrochloride drug variants containing POLYETHYLENE GLYCOL
sitagliptin and metformin hydrochloride drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
sitagliptin and metformin hydrochloride drug variants containing POLYETHYLENE GLYCOL 3350
sitagliptin and metformin hydrochloride drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 8000
sitagliptin and metformin hydrochloride drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | sitagliptin and metformin hydrochloride | 60505-3658 |
| >Company | >Ingredient | >NDC |
sitagliptin and metformin hydrochloride drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYVINYL ALCOHOL
sitagliptin and metformin hydrochloride drug variants containing POLYVINYL ALCOHOL
sitagliptin and metformin hydrochloride drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
sitagliptin and metformin hydrochloride drug variants containing POVIDONE
sitagliptin and metformin hydrochloride drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
sitagliptin and metformin hydrochloride drug variants containing POVIDONE K30
sitagliptin and metformin hydrochloride drug variants not containing POVIDONE K30
Excipient focus: PROPYL GALLATE
sitagliptin and metformin hydrochloride drug variants containing PROPYL GALLATE
sitagliptin and metformin hydrochloride drug variants not containing PROPYL GALLATE
Excipient focus: SILICON DIOXIDE
sitagliptin and metformin hydrochloride drug variants containing SILICON DIOXIDE
sitagliptin and metformin hydrochloride drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
sitagliptin and metformin hydrochloride drug variants containing SODIUM LAURYL SULFATE
sitagliptin and metformin hydrochloride drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STEARYL FUMARATE
sitagliptin and metformin hydrochloride drug variants containing SODIUM STEARYL FUMARATE
sitagliptin and metformin hydrochloride drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | sitagliptin and metformin hydrochloride | 60505-3658 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
sitagliptin and metformin hydrochloride drug variants containing STARCH, CORN
sitagliptin and metformin hydrochloride drug variants not containing STARCH, CORN
Excipient focus: TALC
sitagliptin and metformin hydrochloride drug variants containing TALC
sitagliptin and metformin hydrochloride drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
sitagliptin and metformin hydrochloride drug variants containing TITANIUM DIOXIDE
sitagliptin and metformin hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
sitagliptin and metformin hydrochloride drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | sitagliptin and metformin hydrochloride | 0781-5801 |
| >Company | >Ingredient | >NDC |
sitagliptin and metformin hydrochloride drug variants not containing TRIETHYL CITRATE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links